| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| prgn-3005 | ovarian carcinoma antigen ca125 | NA | Clinical trial target | TTD | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Hematologic Neoplasms[MeSHID:D019337] |
NA | phase 1 | unknown |
| click here to return to the previous page | ||||||||